Yes, intra tumor heterogeneity can be quantified using various metrics and models. Techniques like clonal evolution analysis and computational modeling help in quantifying the extent of heterogeneity within a tumor. These quantifications can be used to tailor treatment plans and to monitor the effectiveness of therapies over time.
